Research Article

The Relation between Sarcopenia and Mortality in Patients at Intensive Care Unit

Table 8

Clinical parameters of survivors and dead patients at follow-up period in ICU.

RecoveryExitus

Gender Median ± SD (median)60,1 ± 18,7 (62)64,5 ± 16,4 (68)0,070
Gender (%)
 Male182 (67,2)56 (61,5)0,328
 Female89 (32,8)35 (38,5)
Cigarette170 (62,7)57 (62,6)1,000
Additional diseases (%)
 Diabetes80 (29,5)36 (39,6)0,076
 Dyspnea142 (52,4)84 (92,3)<0,001
 Renal insufficiency72 (26,6)50 (54,9)<0,001
 Cancer123 (45,4)33 (36,3)0,128
 KKY81 (29,9)34 (37,4)0,185
 KOAH40 (14,8)28 (30,8)0,001
Transfusion (%)155 (57,2)65 (71,4)0,016
Operation (%)202 (74,5)31 (34,1)<0,001
Operation (%)
 Urgent87 (32,1)23 (25,3)<0,001
 Elective115 (42,4)8 (8,8)
 None69 (25,5)60 (65,9)
Type of Anesthesia (%)
 General189 (69,7)30 (33,0)<0,001
 Regional13 (4,8)1 (1,1)
 None69 (25,5)60 (65,9)
Clinic (%)
 Urgent36 (13,3)26 (28,6)<0,001
 Surgical208 (76,8)39 (42,9)
 Internal27 (10,0)26 (28,6)
ASA Score (%)2,4 ± 0,9 (2)2,9 ± 1,1 (3)0,011
 139 (18,9)5 (13,2)0,023
 267 (32,5)8 (21,1)
 377 (37,4)13 (34,2)
 421 (10,2)11 (28,9)
 52 (1,0)1 (2,6)
GCS mean ± SD (Min–Max)13,9 ± 2,6 (15)11,5 ± 4,1 (13)<0,001
 0–820 (7,4)20 (22,2)<0,001
 >9249 (92,6)70 (77,8)
Ventilator need (day) Ave. ± SD (Min–Max)10,6 ± 35,0 (3)18,4 ± 27,6 (7)<0,001
Duration of stay Ave. ± SD (Min–Max)7,2 ± 21,7 (2)19,5 ± 29,2 (8)<0,001